School of Life Sciences, Zhengzhou University, 100 Science Road, Zhengzhou, 450001, PR China.
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450001, PR China.
Exp Cell Res. 2021 Jan 15;398(2):112403. doi: 10.1016/j.yexcr.2020.112403. Epub 2020 Nov 30.
The proliferation of mast cells (MCs) plays a crucial role in either physiological or pathological progression of human physical. C-Kit-mediated signaling pathway has been confirmed to play a key role in MCs proliferation, and the regulatory mechanisms of C-Kit-mediated MCs proliferation need to be further explored. Our previous study found that protein 4.1R could negatively regulate T cell receptor (TCR) mediated signal pathways in CD4 T cells. Little is known about the function of 4.1R in C-Kit-mediated proliferation of MCs. In this study, P815-4.1R cells were constructed by using CRISPR/Cas9 technique. Lack of 4.1R significantly enhanced P815 cells proliferation by accelerating the progression of cell cycle. 4.1R could also significantly alleviate the clinical symptoms of systemic mastocytosis (SM) and improve the overall survival of SM mice. Further study showed that 4.1R could interact directly with C-Kit to inhibit the activation of C-Kit-mediated Ras-Raf-MAPKs and PI3K-AKT signal pathways. Taken together, our findings demonstrate that protein 4.1R, a novel negative regulator, negatively regulates MCs proliferation by inhibiting C-Kit-mediated signal transduction, which maybe provide a potential target to the prevention and treatment of abnormal MCs proliferation-related diseases.
肥大细胞(MCs)的增殖在人体生理或病理进程中起着至关重要的作用。C-Kit 介导的信号通路已被证实在 MCs 增殖中发挥关键作用,需要进一步探索 C-Kit 介导的 MCs 增殖的调控机制。我们之前的研究发现,蛋白 4.1R 可以负调控 CD4 T 细胞中 T 细胞受体(TCR)介导的信号通路。关于 4.1R 在 C-Kit 介导的 MCs 增殖中的作用知之甚少。在这项研究中,我们使用 CRISPR/Cas9 技术构建了 P815-4.1R 细胞。缺乏 4.1R 可通过加速细胞周期进程显著增强 P815 细胞的增殖。4.1R 还可显著减轻系统性肥大细胞增多症(SM)的临床症状并提高 SM 小鼠的总生存率。进一步的研究表明,4.1R 可以直接与 C-Kit 相互作用,抑制 C-Kit 介导的 Ras-Raf-MAPKs 和 PI3K-AKT 信号通路的激活。综上所述,我们的研究结果表明,蛋白 4.1R 作为一种新型负调控因子,通过抑制 C-Kit 介导的信号转导来负调控 MCs 的增殖,这可能为预防和治疗异常 MCs 增殖相关疾病提供潜在靶点。